Shine On You Crazy ...
Health Care: Drugs
Durect Corporation (DRRX: NASDAQ)
$0.95 0.14 | 17.28%
05/21/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 11.20M | 8.90M | 10.44M | 8.29M |
| Receivables | 2.17M | 3.45M | 3.72M | 1.70M |
| Inventories | 3.40M | 3.25M | 2.84M | 2.80M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 36.36M | 37.30M | 54.84M | 47.05M |
| Property, Plant & Equipment, Gross | 22.41M | 22.83M | 24.16M | 24.00M |
| Accumulated Depreciation & Depletion | 19.96M | 19.71M | 22.39M | 20.19M |
| Property, Plant & Equipment, Net | 2.46M | 3.12M | 1.78M | 3.81M |
| Intangibles | 36.00K | 53.00K | 71.00K | 108.00K |
| Other Non-Current Assets | 688.00K | 2.32M | 4.47M | 783.00K |
| Total Non-Current Assets | 9.58M | 11.90M | 12.72M | 11.10M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 45.94M | 49.20M | 67.56M | 58.15M |
| Accounts Payable | 1.78M | 1.27M | 981.00K | 1.02M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 1.36M | 2.32M | 1.20M |
| Total Current Liabilities | 6.93M | 14.89M | 17.91M | 12.26M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 508.00K |
| Deferred Income Taxes | 0.00 | 30.09M | 34.85M | 17.54M |
| Other Non-Current Liabilities | 2.68M | 738.00K | 315.00K | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 2.68M | 30.83M | 35.16M | 18.05M |
| Total Liabilities | 9.60M | 45.72M | 53.07M | 30.31M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 36.33M | 3.48M | 14.49M | 27.84M |
| Common Par | 10.00K | 9.00K | 8.00K | 8.00K |
| Additional Paid In Capital | 375.66M | 359.01M | 351.25M | 341.70M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -339.34M | -355.54M | -336.78M | -313.88M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 6.00K | 5.00K | 6.00K | 10.00K |
| Total Capitalization | 36.33M | 3.48M | 14.49M | 28.35M |
| Total Equity | 36.33M | 3.48M | 14.49M | 27.84M |
| Total Liabilities & Stock Equity | 45.94M | 49.20M | 67.56M | 58.15M |
| Total Common Shares Outstanding | 101.88M | 87.55M | 87.05M | 86.76M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 88.43M | 87.41M | 86.87M | 83.43M |
| Diluted Weighted Shares Outstanding | 88.59M | 87.41M | 86.87M | 83.43M |
| Number of Employees | 102 | 106 | 131 | 127 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with DRRX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ProRobert Bruce
- Userdonellisor
- UserTrading
- Userbaustin002 Portfolio 1
- UserBarron's Research Reports 1...
Latest DRRX Headlines from TheStreet
- 4 Stocks Under $5 Moving Higher 03.19.13 | 03:03 pm
- 4 Stocks Under $5 Making Big Moves 02.26.13 | 02:02 pm
- 5 Stocks Setting Up to Break Out 01.25.13 | 01:01 pm
- 8 Stocks Under $10 Making Big Moves 08.30.12 | 02:08 pm
- Durect Corporation Stock Upgraded (DRRX) 07.24.12 | 05:07 am
- Alkermes Needs to Build on Drug Delivery Success 06.18.12 | 07:06 am
- Business Highlights 06.24.11 | 06:06 pm
- Durect Stock Gaps Down On Today's Open (DRRX) 06.24.11 | 09:06 am
- Pfizer, Pain Therapeutics Drug Rejected by FDA 06.24.11 | 08:06 am
- 10 Stocks to Watch: Alcoa, BP 04.12.11 | 06:04 am
Press Releases for DRRX
- DURECT Announces Submission Of New Drug Application For POSIDUR⿢ (SABER®-Bupivacaine) - PR Newswire 04.16.13 | 07:04 am
- DURECT Corporation Invites You To Join Its Fourth Quarter 2012 Earnings Conference Call - PR Newswire 02.22.13 | 08:02 am
- DURECT To Participate In Upcoming Healthcare Conferences - PR Newswire 02.05.13 | 08:02 am
- DURECT Announces Positive Results From Reldayâ¿¢ Phase 1 Clinical Trial - PR Newswire 01.03.13 | 07:01 am
- DURECT Announces Pricing Of Public Offering Of Common Stock - PR Newswire 12.06.12 | 07:12 am
- DURECT To Participate In Upcoming Healthcare Conferences - PR Newswire 11.13.12 | 09:11 am
- DURECT Corporation Invites You To Join Its Third Quarter 2012 Earnings Conference Call - PR Newswire 10.30.12 | 04:10 pm
- DURECT To Participate In Upcoming Healthcare Conferences - PR Newswire 08.21.12 | 08:08 am
- DURECT Announces Intent To Submit NDA For POSIDUR⢠For Post-Operative Analgesia - PR Newswire 08.06.12 | 04:08 pm
- DURECT Corporation Invites You To Join Its Second Quarter 2012 Earnings Conference Call - PR Newswire 07.26.12 | 04:07 pm
Partner Headlines for DRRX
- A Study Of 3 Biotechs - A Story Of Hope, Potential And Partnerships - Seeking Alpha 03.18.13 | 09:03 am
- Durect Offers Two Shots On Goal, Almost 100% Upside - Seeking Alpha 02.26.13 | 09:02 am
- 3 Best Biotech Stocks For This Week (Part V) - Seeking Alpha 10.08.12 | 09:10 am
- DRRX - Initiating Coverage of DURECT Corp. - Analyst Blog - NASDAQ 09.11.12 | 02:09 pm
- Benzinga's Microcap Movers for Friday July 20, 2012 - Benzinga 07.21.12 | 05:07 pm
- Pfizer Terminates Development and License Agreement Between Alpharma Ireland and DURECT - Benzinga 03.01.12 | 04:03 pm
- DURECT Announces Top-line Data from BESST; Did Not Reach Statistical Significance - Benzinga 01.05.12 | 04:01 pm
- 12 Healthcare Companies Looking at June Catalysts - Seeking Alpha 05.30.11 | 04:05 am
- Jefferies Reiterates Buy Rating on DURECT Corp. (DRRX) - Benzinga 08.05.10 | 09:08 am
- FDA Clears Hospira's Generic Drug - Analyst Blog - Zacks 06.25.10 | 01:06 pm
